e8vk
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported) October 20, 2003

eXegenics Inc.

(Exact name of registrant as specified in its charter)
         
Delaware   00-26078   75-2402409
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

2110 Research Row

Dallas, Texas 75235

(Address of principal executive
offices including zip code)

(214) 358-2000

(Registrant’s telephone number,
including area code)

N.A.


(Former name or former address, if changed since last report)

 


TABLE OF CONTENTS

Item 5. Other Events and Regulation FD Disclosure.
Item 7. Financial Statements and Exhibits.
SIGNATURES
Index to Exhibits
EX-99.1 Press Release


Table of Contents

Item 5. Other Events and Regulation FD Disclosure.

     On October 24, 2003, the registrant issued a press release, a copy of which is filed herewith as Exhibit 99.1 and incorporated herein by reference.

Item 7. Financial Statements and Exhibits.

     (c) The following exhibits are furnished with this report:

     
Exhibit Number   Description

 
99.1   Press Release from eXegenics Inc., dated October 24, 2003.

 


Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

             
    eXegenics Inc.
(Registrant)
             
Dated: October 24, 2003   By:   /s/ Ronald L. Goode    
       
   
        Ronald L. Goode
Chairman, President and Chief Executive Officer
   

 


Table of Contents

Index to Exhibits

     
Exhibit Number   Description

 
99.1   Press Release from eXegenics Inc., dated October 24, 2003.